首页 > 最新文献

Quality in health care : QHC最新文献

英文 中文
The Evidence-Based Primary Care Handbook.: Mark Gabbay, editor. (Pp 314; pound19.50). London: Royal Society of Medicine, 1999. 1 85315 415 6Quality in Health Care 2000;9:264-265. 循证初级保健手册。马克·加贝,编辑。(页314;pound19.50)。伦敦:皇家医学学会,1999。1 85315 415 6保健质量2000;9:264-265。
Pub Date : 2000-12-01 DOI: 10.1136/qhc.9.4.264
Baker
{"title":"The Evidence-Based Primary Care Handbook.: Mark Gabbay, editor. (Pp 314; pound19.50). London: Royal Society of Medicine, 1999. 1 85315 415 6Quality in Health Care 2000;9:264-265.","authors":"Baker","doi":"10.1136/qhc.9.4.264","DOIUrl":"https://doi.org/10.1136/qhc.9.4.264","url":null,"abstract":"","PeriodicalId":20773,"journal":{"name":"Quality in health care : QHC","volume":"9 4","pages":"264"},"PeriodicalIF":0.0,"publicationDate":"2000-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/qhc.9.4.264","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21925400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Complications of diabetes: renal disease and promotion of self-management. 糖尿病并发症:肾脏疾病和促进自我管理。
Pub Date : 2000-12-01 DOI: 10.1136/qhc.9.4.257
A Melville, R Richardson, D Lister-Sharp, A McIntosh
This paper is an edited version of Effective Health Care volume 6 number 1,1 which summarises information originally derived from systematic reviews undertaken to inform national clinical practice guidelines,23 supplemented and re-analysed by the NHS Centre for Reviews and Dissemination.Raised blood glucose levels and related microvascular disease are associated with progressive damage to the kidneys. This damage becomes detectable when protein (primarily albumin) is excreted in the urine in higher concentrations than normal. As the severity of the damage increases, the quantity of protein in the urine also increases. When the level of albumin in the urine is fairly low, the condition is known as microalbuminuria or incipient nephropathy; higher albumin excretion is described as proteinuria. Eventually the condition can lead to renal failure.2Epidemiological studies report prevalence rates of microalbuminuria in patients with type 2 diabetes ranging from 8% to 32% with most estimates being around 25%.4–15 Prevalence estimates for proteinuria range from 5% to 19% with most studies giving rates of around 15%.569–111516 This variation may be a product of the criteria used to define the condition, the stage of the disease, and the methods used to assess it. Figures from the UK Prospective Diabetes Study (UKPDS), based on 3867 patients, suggest that about 12% have microalbuminuria (although using a high threshold) and 1.9% have proteinuria at the time of diagnosis of diabetes.17 A US study which followed 794 patients with type 2 diabetes who were initially free from proteinuria (defined as ≥30 μg protein/l urine) found that 1.3% developed renal failure within 10 years.18A substantial proportion of patients treated in renal units in the UK have diabetes. Diabetic nephropathy is the most common single cause of renal failure among …
{"title":"Complications of diabetes: renal disease and promotion of self-management.","authors":"A Melville, R Richardson, D Lister-Sharp, A McIntosh","doi":"10.1136/qhc.9.4.257","DOIUrl":"https://doi.org/10.1136/qhc.9.4.257","url":null,"abstract":"This paper is an edited version of Effective Health Care volume 6 number 1,1 which summarises information originally derived from systematic reviews undertaken to inform national clinical practice guidelines,23 supplemented and re-analysed by the NHS Centre for Reviews and Dissemination.\u0000\u0000Raised blood glucose levels and related microvascular disease are associated with progressive damage to the kidneys. This damage becomes detectable when protein (primarily albumin) is excreted in the urine in higher concentrations than normal. As the severity of the damage increases, the quantity of protein in the urine also increases. When the level of albumin in the urine is fairly low, the condition is known as microalbuminuria or incipient nephropathy; higher albumin excretion is described as proteinuria. Eventually the condition can lead to renal failure.2\u0000\u0000Epidemiological studies report prevalence rates of microalbuminuria in patients with type 2 diabetes ranging from 8% to 32% with most estimates being around 25%.4–15 Prevalence estimates for proteinuria range from 5% to 19% with most studies giving rates of around 15%.569–111516 This variation may be a product of the criteria used to define the condition, the stage of the disease, and the methods used to assess it. Figures from the UK Prospective Diabetes Study (UKPDS), based on 3867 patients, suggest that about 12% have microalbuminuria (although using a high threshold) and 1.9% have proteinuria at the time of diagnosis of diabetes.17 A US study which followed 794 patients with type 2 diabetes who were initially free from proteinuria (defined as ≥30 μg protein/l urine) found that 1.3% developed renal failure within 10 years.18\u0000\u0000A substantial proportion of patients treated in renal units in the UK have diabetes. Diabetic nephropathy is the most common single cause of renal failure among …","PeriodicalId":20773,"journal":{"name":"Quality in health care : QHC","volume":"9 4","pages":"257-63"},"PeriodicalIF":0.0,"publicationDate":"2000-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/qhc.9.4.257","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21925402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
Modern measurement for a modern health service. 现代卫生服务的现代计量。
Pub Date : 2000-12-01 DOI: 10.1136/qhc.9.4.199
P M Wilcock, R G Thomson
The use of performance measures that enable aspects of health care delivered in different institutions to be compared are fraught with difficulties. However, despite inherent international concerns—about validity, comparability, and usefulness—they are here to stay. The challenge for all health systems is to find ways of using performance measures to promote real improvements in care. Questions such as whether public disclosure of comparative performance measures should be used to make external judgements—for example, in the form of league tables—or whether are they better used as tools for internal reflection to support quality improvement are the focus of active international debate. Changes in the use of performance data in any system have implications for others.1 The new approach to be implemented in the UK will therefore be watched with interest.The recently published 10 year plan for the NHS2 contained an initiative that has profound implications for both performance management and quality of care. The NHS performance assessment framework (PAF)3 already makes comparative indicator data publicly available, including clinical indicators such as readmission rates and perioperative mortality rates. The annual publication of these performance indicators4 by the NHS is about to be supplemented by a new “traffic light” …
{"title":"Modern measurement for a modern health service.","authors":"P M Wilcock, R G Thomson","doi":"10.1136/qhc.9.4.199","DOIUrl":"https://doi.org/10.1136/qhc.9.4.199","url":null,"abstract":"The use of performance measures that enable aspects of health care delivered in different institutions to be compared are fraught with difficulties. However, despite inherent international concerns—about validity, comparability, and usefulness—they are here to stay. The challenge for all health systems is to find ways of using performance measures to promote real improvements in care. Questions such as whether public disclosure of comparative performance measures should be used to make external judgements—for example, in the form of league tables—or whether are they better used as tools for internal reflection to support quality improvement are the focus of active international debate. Changes in the use of performance data in any system have implications for others.1 The new approach to be implemented in the UK will therefore be watched with interest.\u0000\u0000The recently published 10 year plan for the NHS2 contained an initiative that has profound implications for both performance management and quality of care. The NHS performance assessment framework (PAF)3 already makes comparative indicator data publicly available, including clinical indicators such as readmission rates and perioperative mortality rates. The annual publication of these performance indicators4 by the NHS is about to be supplemented by a new “traffic light” …","PeriodicalId":20773,"journal":{"name":"Quality in health care : QHC","volume":"9 4","pages":"199-200"},"PeriodicalIF":0.0,"publicationDate":"2000-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/qhc.9.4.199","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21926139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 56
Evidence-based patient empowerment. 基于证据的患者赋权。
Pub Date : 2000-12-01 DOI: 10.1136/qhc.9.4.200
M Wensing
{"title":"Evidence-based patient empowerment.","authors":"M Wensing","doi":"10.1136/qhc.9.4.200","DOIUrl":"https://doi.org/10.1136/qhc.9.4.200","url":null,"abstract":"","PeriodicalId":20773,"journal":{"name":"Quality in health care : QHC","volume":"9 4","pages":"200-1"},"PeriodicalIF":0.0,"publicationDate":"2000-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/qhc.9.4.200","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21925391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
New Zealand and United Kingdom experiences with the RAND modified Delphi approach to producing angina and heart failure criteria for quality assessment in general practice. 新西兰和英国的经验与兰德修改德尔福方法制定心绞痛和心力衰竭的质量评估标准在一般做法。
Pub Date : 2000-12-01 DOI: 10.1136/qhc.9.4.222
S A Buetow, G D Coster

Objectives: (1) To describe the development of minimum review criteria for the general practice management in New Zealand (NZ) of two chronic diseases: stable angina and systolic heart failure, and (2) to compare the NZ angina criteria with a set produced in Manchester to assess the extent to which use of the same approach to criteria development yields similar criteria.

Methods: A modified Delphi approach, based on the RAND consensus panel method, was used to produce minimum criteria for reviewing the recorded management of heart failure and angina in NZ general practice. The criteria for angina were compared with those produced in the UK, including assessment of the extent to which each set describes actions that the other panel agrees are necessary to record.

Results: For each condition we report minimum criteria describing actions rated as (a) necessary to record and (b) inappropriate to take but, if taken, necessary to record. Although strong scientific evidence underpins approximately one quarter and one third, respectively, of the final sets of NZ and UK angina criteria for actions necessary to record, the NZ criteria agree strongly with the UK criteria (33 of 39 criteria, 85%) but there is less UK agreement with the NZ angina criteria (28 of 40 criteria, 70%).

Conclusion: Despite the lack of scientific evidence for up to three quarters of angina care in general practice, the RAND based approach to criteria development was used in NZ to reproduce most of the UK angina criteria for actions rated as necessary to record in general practice. It is important to make explicit whether ratings of necessity and appropriateness apply to the recording of actions or to the actions themselves.

目的:(1)描述新西兰(NZ)两种慢性疾病:稳定型心绞痛和收缩期心力衰竭的一般实践管理最低审查标准的发展,(2)将新西兰心绞痛标准与曼彻斯特制定的一套标准进行比较,以评估使用相同方法制定标准产生相似标准的程度。方法:基于RAND共识小组方法,采用改进的德尔菲法,对新西兰全科实践中心力衰竭和心绞痛的记录管理制定最低标准。心绞痛的标准与英国制定的标准进行了比较,包括评估每一组描述的行动的程度,其他小组同意有必要记录。结果:对于每一种情况,我们报告了描述行动的最低标准,这些行动被评为(a)有必要记录,(b)不适宜采取,但如果采取了,有必要记录。虽然强有力的科学证据分别支持了大约四分之一和三分之一的新西兰和英国最终的心绞痛标准,以记录必要的行动,新西兰标准与英国标准非常一致(39个标准中的33个,85%),但英国与新西兰心绞痛标准的一致性较低(40个标准中的28个,70%)。结论:尽管在全科实践中多达四分之三的心绞痛护理缺乏科学证据,但在新西兰,基于RAND的标准制定方法被用于复制大多数英国心绞痛标准,这些标准被认为是全科实践中必须记录的行为。必须明确说明必要性和适当性的等级是适用于行动的记录还是适用于行动本身。
{"title":"New Zealand and United Kingdom experiences with the RAND modified Delphi approach to producing angina and heart failure criteria for quality assessment in general practice.","authors":"S A Buetow,&nbsp;G D Coster","doi":"10.1136/qhc.9.4.222","DOIUrl":"https://doi.org/10.1136/qhc.9.4.222","url":null,"abstract":"<p><strong>Objectives: </strong>(1) To describe the development of minimum review criteria for the general practice management in New Zealand (NZ) of two chronic diseases: stable angina and systolic heart failure, and (2) to compare the NZ angina criteria with a set produced in Manchester to assess the extent to which use of the same approach to criteria development yields similar criteria.</p><p><strong>Methods: </strong>A modified Delphi approach, based on the RAND consensus panel method, was used to produce minimum criteria for reviewing the recorded management of heart failure and angina in NZ general practice. The criteria for angina were compared with those produced in the UK, including assessment of the extent to which each set describes actions that the other panel agrees are necessary to record.</p><p><strong>Results: </strong>For each condition we report minimum criteria describing actions rated as (a) necessary to record and (b) inappropriate to take but, if taken, necessary to record. Although strong scientific evidence underpins approximately one quarter and one third, respectively, of the final sets of NZ and UK angina criteria for actions necessary to record, the NZ criteria agree strongly with the UK criteria (33 of 39 criteria, 85%) but there is less UK agreement with the NZ angina criteria (28 of 40 criteria, 70%).</p><p><strong>Conclusion: </strong>Despite the lack of scientific evidence for up to three quarters of angina care in general practice, the RAND based approach to criteria development was used in NZ to reproduce most of the UK angina criteria for actions rated as necessary to record in general practice. It is important to make explicit whether ratings of necessity and appropriateness apply to the recording of actions or to the actions themselves.</p>","PeriodicalId":20773,"journal":{"name":"Quality in health care : QHC","volume":"9 4","pages":"222-31"},"PeriodicalIF":0.0,"publicationDate":"2000-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/qhc.9.4.222","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21925396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
What is a prescribing error? 什么是处方错误?
Pub Date : 2000-12-01 DOI: 10.1136/qhc.9.4.232
B Dean, N Barber, M Schachter

Objective: To develop a practitioner led definition of a prescribing error for use in quantitative studies of their incidence.

Design: Two stage Delphi technique.

Subjects: A panel of 34 UK judges, which included physicians, surgeons, pharmacists, nurses and risk managers.

Main outcome measures: The extent to which judges agreed with a general definition of a prescribing error, and the extent to which they agreed that each of 42 scenarios represented a prescribing error.

Results: Responses were obtained from 30 (88%) of 34 judges in the first Delphi round, and from 26 (87%) of 30 in the second round. The general definition of a prescribing error was accepted. The panel reached consensus that 24 of the 42 scenarios should be included as prescribing errors and that five should be excluded. In general, transcription errors, failure to communicate essential information, and the use of drugs or doses inappropriate for the individual patient were considered prescribing errors; deviations from policies or guidelines were not.

Conclusions: Health care professionals are in broad agreement about the types of events that should be included and excluded as prescribing errors. A general definition of a prescribing error has been developed, together with more detailed guidance regarding the types of events that should be included. This definition allows the comparison of prescribing error rates among different prescribing systems and different hospitals, and is suitable for use in both research and clinical governance initiatives.

目的:开发一个由医生主导的处方错误的定义,用于其发生率的定量研究。设计:两级德尔菲法。受试者:一个由34名英国评委组成的小组,其中包括内科医生、外科医生、药剂师、护士和风险管理人员。主要结果测量:法官同意处方错误的一般定义的程度,以及他们同意42种情况中的每一种都代表处方错误的程度。结果:34名评委中有30人(88%)在第一轮德尔菲中回答,30名评委中有26人(87%)在第二轮德尔菲中回答。处方错误的一般定义被接受。专家组达成共识,认为42种情况中的24种应列入处方错误,5种应排除在外。一般来说,转录错误、未能传达基本信息、使用药物或剂量不适合个体患者被认为是处方错误;偏离政策或指导方针则不是。结论:卫生保健专业人员对应纳入和排除处方错误的事件类型有广泛的共识。已经制定了处方错误的一般定义,以及关于应包括的事件类型的更详细的指导。该定义允许比较不同处方系统和不同医院之间的处方错误率,适用于研究和临床治理计划。
{"title":"What is a prescribing error?","authors":"B Dean,&nbsp;N Barber,&nbsp;M Schachter","doi":"10.1136/qhc.9.4.232","DOIUrl":"https://doi.org/10.1136/qhc.9.4.232","url":null,"abstract":"<p><strong>Objective: </strong>To develop a practitioner led definition of a prescribing error for use in quantitative studies of their incidence.</p><p><strong>Design: </strong>Two stage Delphi technique.</p><p><strong>Subjects: </strong>A panel of 34 UK judges, which included physicians, surgeons, pharmacists, nurses and risk managers.</p><p><strong>Main outcome measures: </strong>The extent to which judges agreed with a general definition of a prescribing error, and the extent to which they agreed that each of 42 scenarios represented a prescribing error.</p><p><strong>Results: </strong>Responses were obtained from 30 (88%) of 34 judges in the first Delphi round, and from 26 (87%) of 30 in the second round. The general definition of a prescribing error was accepted. The panel reached consensus that 24 of the 42 scenarios should be included as prescribing errors and that five should be excluded. In general, transcription errors, failure to communicate essential information, and the use of drugs or doses inappropriate for the individual patient were considered prescribing errors; deviations from policies or guidelines were not.</p><p><strong>Conclusions: </strong>Health care professionals are in broad agreement about the types of events that should be included and excluded as prescribing errors. A general definition of a prescribing error has been developed, together with more detailed guidance regarding the types of events that should be included. This definition allows the comparison of prescribing error rates among different prescribing systems and different hospitals, and is suitable for use in both research and clinical governance initiatives.</p>","PeriodicalId":20773,"journal":{"name":"Quality in health care : QHC","volume":"9 4","pages":"232-7"},"PeriodicalIF":0.0,"publicationDate":"2000-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/qhc.9.4.232","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21925397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 413
Consumer and professional standards: working towards consensus. 消费者和专业标准:努力达成共识。
Pub Date : 2000-09-01 DOI: 10.1136/qhc.9.3.190
C Williamson

Standards of treatment and care should be acceptable to healthcare consumers as well as to healthcare professionals. A simple categorisation of standards according to their acceptability to consumers is outlined. Professional/consumer groups which review and set standards are discussed, with emphasis on the principles of partnership. Working together towards consensus can be difficult but is now an important way forward.

医疗保健消费者和医疗保健专业人员都应该接受治疗和护理标准。根据消费者的接受程度,对标准进行了简单的分类。讨论了审查和制定标准的专业/消费者团体,重点是伙伴关系原则。为达成共识而共同努力可能很困难,但现在这是一条重要的前进道路。
{"title":"Consumer and professional standards: working towards consensus.","authors":"C Williamson","doi":"10.1136/qhc.9.3.190","DOIUrl":"https://doi.org/10.1136/qhc.9.3.190","url":null,"abstract":"<p><p>Standards of treatment and care should be acceptable to healthcare consumers as well as to healthcare professionals. A simple categorisation of standards according to their acceptability to consumers is outlined. Professional/consumer groups which review and set standards are discussed, with emphasis on the principles of partnership. Working together towards consensus can be difficult but is now an important way forward.</p>","PeriodicalId":20773,"journal":{"name":"Quality in health care : QHC","volume":"9 3","pages":"190-4"},"PeriodicalIF":0.0,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/qhc.9.3.190","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21814078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Quality improvement programme for cardiovascular disease risk factor recording in primary care. 初级保健中心血管疾病危险因素记录的质量改进方案。
Pub Date : 2000-09-01 DOI: 10.1136/qhc.9.3.175
E Ketola, R Sipilä, M Mäkelä, M Klockars

Objectives: Evaluation of the effect of a quality improvement programme on cardiovascular disease (CVD) risk factor recording and risk factor levels in a controlled study at two primary health care centres serving 26,000 inhabitants in Northern Helsinki.

Methods: From a random sample of patient records from 1995 (n=1,066), 1996 (n=1,042), and 1997 (n=1,040) the frequency of CVD risk factor recording was measured and the changes in mean levels of total cholesterol, blood glucose, blood pressure, and body weight were monitored during the follow up period. The intervention programme (1995-1996) consisted of lectures and meetings of multiprofessional teams, development of local guidelines, and introduction of a structured risk factor recording sheet as part of the patient records.

Results: After the quality improvement period all risk factors were better recorded at the intervention station than at the control station (p<0.001). More high risk CVD patients were detected from the general population at the intervention station. The mean values of most measured risk factors changed during the intervention. During the follow up period differences were observed between the two health stations in the time trends for body weight, body mass index (BMI), total cholesterol, and glucose levels. Risk factor levels of high risk patients receiving CVD treatment decreased during the intervention.

Conclusions: A simple quality improvement programme improved the practice of recording risk factors for CVD which resulted in earlier detection of patients with a high risk of developing the disease.

目标:在为赫尔辛基北部26,000名居民提供服务的两个初级保健中心进行的一项对照研究中,评估质量改进方案对心血管疾病风险因素记录和风险因素水平的影响。方法:随机抽取1995年(n= 1066)、1996年(n= 1042)、1997年(n= 1040)的患者记录,记录心血管疾病危险因素的发生频率,并监测随访期间患者总胆固醇、血糖、血压、体重的变化情况。干预方案(1995-1996年)包括讲座和多专业小组会议,制定当地指导方针,并引入结构化风险因素记录表作为患者记录的一部分。结果:质量改善期结束后,干预站的所有危险因素记录均优于对照站。结论:简单的质量改善方案改善了记录心血管疾病危险因素的做法,可早期发现高危患者。
{"title":"Quality improvement programme for cardiovascular disease risk factor recording in primary care.","authors":"E Ketola,&nbsp;R Sipilä,&nbsp;M Mäkelä,&nbsp;M Klockars","doi":"10.1136/qhc.9.3.175","DOIUrl":"https://doi.org/10.1136/qhc.9.3.175","url":null,"abstract":"<p><strong>Objectives: </strong>Evaluation of the effect of a quality improvement programme on cardiovascular disease (CVD) risk factor recording and risk factor levels in a controlled study at two primary health care centres serving 26,000 inhabitants in Northern Helsinki.</p><p><strong>Methods: </strong>From a random sample of patient records from 1995 (n=1,066), 1996 (n=1,042), and 1997 (n=1,040) the frequency of CVD risk factor recording was measured and the changes in mean levels of total cholesterol, blood glucose, blood pressure, and body weight were monitored during the follow up period. The intervention programme (1995-1996) consisted of lectures and meetings of multiprofessional teams, development of local guidelines, and introduction of a structured risk factor recording sheet as part of the patient records.</p><p><strong>Results: </strong>After the quality improvement period all risk factors were better recorded at the intervention station than at the control station (p<0.001). More high risk CVD patients were detected from the general population at the intervention station. The mean values of most measured risk factors changed during the intervention. During the follow up period differences were observed between the two health stations in the time trends for body weight, body mass index (BMI), total cholesterol, and glucose levels. Risk factor levels of high risk patients receiving CVD treatment decreased during the intervention.</p><p><strong>Conclusions: </strong>A simple quality improvement programme improved the practice of recording risk factors for CVD which resulted in earlier detection of patients with a high risk of developing the disease.</p>","PeriodicalId":20773,"journal":{"name":"Quality in health care : QHC","volume":"9 3","pages":"175-80"},"PeriodicalIF":0.0,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/qhc.9.3.175","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21814076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 27
Adverse events in health care. 卫生保健中的不良事件。
Pub Date : 2000-09-01 DOI: 10.1136/qhc.9.3.198
M García-Martín, P Lardelli-Claret, J J Jiménez-Moleón
We welcome Dr Walshe's review of the study of adverse events.1 Dr Walshe points out the usefulness of studies of adverse events, but also the need to be cautious when they are used as measures of health care quality. We think that this article underlines the major methodological issue in studies of adverse events—namely, the lack of a standardised definition. Until this point is resolved, the practical applications of the concept of adverse events will be limited. Definitions of this term are frequently grouped into two categories—restrictive and broader. Restrictive …
{"title":"Adverse events in health care.","authors":"M García-Martín,&nbsp;P Lardelli-Claret,&nbsp;J J Jiménez-Moleón","doi":"10.1136/qhc.9.3.198","DOIUrl":"https://doi.org/10.1136/qhc.9.3.198","url":null,"abstract":"We welcome Dr Walshe's review of the study of adverse events.1 Dr Walshe points out the usefulness of studies of adverse events, but also the need to be cautious when they are used as measures of health care quality. We think that this article underlines the major methodological issue in studies of adverse events—namely, the lack of a standardised definition. Until this point is resolved, the practical applications of the concept of adverse events will be limited. Definitions of this term are frequently grouped into two categories—restrictive and broader. Restrictive …","PeriodicalId":20773,"journal":{"name":"Quality in health care : QHC","volume":"9 3","pages":"198"},"PeriodicalIF":0.0,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/qhc.9.3.198","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21814079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Information technology for quality health care: a summary of United Kingdom and United States experiences. 信息技术促进高质量卫生保健:英国和美国经验总结。
Pub Date : 2000-09-01 DOI: 10.1136/qhc.9.3.181
D E Detmer
“ What is new and significant must always be connected with old roots, the truly vital roots that are chosen with great care from the ones that merely survive .” Bela Bartok The explicit use of health information technology (HIT) to enable threshold improvements in the delivery of health care services is beginning to emerge as a serious objective for health care organisations and systems. Many readers who are very knowledgeable of quality measurement are relatively uninformed about health informatics and the converse is also true. It is for these readers that this paper is written. Specifically, the objective of this review of HIT in the UK and USA will focus upon salient features, deployment, and related policy issues. Particular attention will be given to areas in which threshold improvements in quality now exist or are likely to be forthcoming. Comments are organised to relate at the level of the individual, teams or microsystems, organisations, and larger systems, including national information infrastructures.Health care information technology is a broader phenomenon than it is deep. Over the past 30 years the information technology revolution developed slowly from roots in Turing's military intelligence machines of World War II to DARPA and the present day Internet when the pace picked up. While the telephone took 40 years to reach 10 million people, it only took 4–5 years for the Internet to reach 100 million. Despite successes being clouded by hype and hope, the Internet consumer health market is projected to reach $1.7 billion by 2003.Randomised trials now confirm the early evidence that health care quality can be significantly improved through health informatics.1 Evidence of improved access and cost effectiveness should soon follow.2 Over the next two decades e-health could deliver patient, provider, and planner/manager interactions for all aspects of health …
{"title":"Information technology for quality health care: a summary of United Kingdom and United States experiences.","authors":"D E Detmer","doi":"10.1136/qhc.9.3.181","DOIUrl":"https://doi.org/10.1136/qhc.9.3.181","url":null,"abstract":"“ What is new and significant must always be connected with old roots, the truly vital roots that are chosen with great care from the ones that merely survive .” Bela Bartok \u0000\u0000The explicit use of health information technology (HIT) to enable threshold improvements in the delivery of health care services is beginning to emerge as a serious objective for health care organisations and systems. Many readers who are very knowledgeable of quality measurement are relatively uninformed about health informatics and the converse is also true. It is for these readers that this paper is written. Specifically, the objective of this review of HIT in the UK and USA will focus upon salient features, deployment, and related policy issues. Particular attention will be given to areas in which threshold improvements in quality now exist or are likely to be forthcoming. Comments are organised to relate at the level of the individual, teams or microsystems, organisations, and larger systems, including national information infrastructures.\u0000\u0000Health care information technology is a broader phenomenon than it is deep. Over the past 30 years the information technology revolution developed slowly from roots in Turing's military intelligence machines of World War II to DARPA and the present day Internet when the pace picked up. While the telephone took 40 years to reach 10 million people, it only took 4–5 years for the Internet to reach 100 million. Despite successes being clouded by hype and hope, the Internet consumer health market is projected to reach $1.7 billion by 2003.\u0000\u0000Randomised trials now confirm the early evidence that health care quality can be significantly improved through health informatics.1 Evidence of improved access and cost effectiveness should soon follow.2 Over the next two decades e-health could deliver patient, provider, and planner/manager interactions for all aspects of health …","PeriodicalId":20773,"journal":{"name":"Quality in health care : QHC","volume":"9 3","pages":"181-9"},"PeriodicalIF":0.0,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/qhc.9.3.181","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21814077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 58
期刊
Quality in health care : QHC
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1